Home » Topics » BioWorld Science

BioWorld Science
RSS

Xenon Pharmaceuticals divulges Nav1.6 channel blockers

July 3, 2018

FDA approves Aristada Initio

July 3, 2018

University of Texas System synthesizes MAP3K12 inhibitors

July 3, 2018

Neovacs reports phase IIb results for IFN-alpha kinoid in moderate to severe lupus

July 3, 2018

Merck & Co. presents FFA1 receptor agonists

July 3, 2018

FDA grants priority review to sBLA for Keytruda with chemotherapy in first-line metastatic NSCLC

July 3, 2018

NovaTarg divulges new AMPK activators for diabetes

July 3, 2018

Entyvio approved in Japan for ulcerative colitis

July 3, 2018

Glactone Pharma Development patents STAT3 inhibitors

July 3, 2018

Dafclir receives approval in Japan

July 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...